Oragenics(OGEN)
$0.34-0.00 (-0.58%)
OGEN
Oragenics financials statements
$0.34
At close:-0.00 (-0.58%)
Want to see OGEN full AI Analyst Report?
Oragenics (OGEN) Ratios
1,057 Followers
Oragenics Ratios
OGEN's free cash flow for Q2 2026 was $-2.19M. For the 2026 fiscal year, OGEN's free cash flow was increased by $0.00 and operating cash flow was $-2.19M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.64 | 0.87 | 2.15 | 8.95 | 19.17 |
| Quick Ratio | 5.64 | 0.87 | 2.15 | 8.95 | 19.17 |
| Cash Ratio | 2.46 | 0.51 | 1.94 | 7.16 | 18.87 |
| Solvency Ratio | -5.51 | -6.27 | -11.47 | -8.15 | -8.98 |
| Operating Cash Flow Ratio | -5.18 | -5.10 | -4.05 | -9.54 | -9.32 |
| Short-Term Operating Cash Flow Coverage | -40.67 | -26.17 | -23.32 | -56.90 | -44.40 |
| Net Current Asset Value | $ 8.28M | $ -211.88K | $ 2.07M | $ 12.54M | $ 25.96M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.22 | 0.06 | 0.04 | 0.03 |
| Debt-to-Equity Ratio | 0.03 | -1.55 | 0.10 | 0.05 | 0.03 |
| Debt-to-Capital Ratio | 0.03 | 2.82 | 0.09 | 0.05 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.22 | -6.95 | 1.57 | 1.13 | 1.07 |
| Debt Service Coverage Ratio | -8.94 | -29.41 | -65.87 | -50.32 | -49.05 |
| Interest Coverage Ratio | -11.91 | -353.99 | 0.00 | -954.83 | -1000.95 |
| Debt to Market Cap | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.47 | 0.05 | 0.14 | 0.32 | 0.43 |
| Net Debt to EBITDA | 0.45 | 0.05 | 0.15 | 0.76 | 1.69 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 98.63% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 106.59% | 100.09% | 98.81% | 99.08% | 99.62% |
| Return on Assets (ROA) | -97.76% | -717.68% | -415.92% | -96.82% | -55.65% |
| Return on Equity (ROE) | -118.85% | 4987.57% | -651.98% | -109.83% | -59.32% |
| Return on Capital Employed (ROCE) | -113.05% | 4983.28% | -659.84% | -109.57% | -58.88% |
| Return on Invested Capital (ROIC) | -108.52% | -9052.25% | -598.88% | -105.77% | -57.80% |
| Return on Tangible Assets | -97.76% | -717.68% | -415.92% | -96.82% | -55.65% |
| Earnings Yield | -582.59% | -14.40% | -5.44% | -3.76% | -1.04% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -4.29 | -1.30 | -3.24 | -7.58 | -7.16 |
| Free Cash Flow Per Share | -4.29 | -1.30 | -3.68 | -7.64 | -7.18 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -7.29 | -119.42 | -11.60 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -7.29 | -119.42 | -307.01 |
| Operating Cash Flow Coverage Ratio | -40.67 | -26.17 | -22.61 | -24.38 | -16.90 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -547.31% | -11.72% | -2.18% | -4.04% | -0.89% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.17 | -6.92 | -18.40 | -26.60 | -96.16 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.20 | -346.28 | 119.95 | 29.21 | 57.04 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.18 | -8.53 | -45.84 | -24.75 | -111.80 |
| Price-to-Operating Cash Flow Ratio | -0.18 | -8.53 | -52.12 | -24.96 | -112.16 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.08 | -0.63 | 2.20 | 1.35 |
| Enterprise Value Multiple | 0.27 | -6.91 | -18.30 | -25.95 | -94.82 |
| Enterprise Value | -2.48M | 72.84M | 376.86M | 369.26M | 1.48B |
| EV to EBITDA | 0.27 | -6.91 | -18.30 | -25.95 | -94.82 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | 0.27 | -8.47 | -45.46 | -24.05 | -109.84 |
| EV to Operating Cash Flow | 0.27 | -8.47 | -51.69 | -24.25 | -110.20 |
| Tangible Book Value Per Share | 3.84 | -0.03 | 1.41 | 6.48 | 14.07 |
| Shareholders’ Equity Per Share | 3.84 | -0.03 | 1.41 | 6.48 | 14.07 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -4.56 | -1.60 | -9.18 | -7.11 | -8.35 |
| Tax Burden | 0.99 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.09 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.94 | 0.81 | 0.35 | 1.07 | 0.86 |
Currency in USD
